These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18525185)

  • 1. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
    Nagaki M; Shimizu M; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
    Wang L; Levin MS
    Gastroenterology; 2005 Jan; 128(1):228-31. PubMed ID: 15633140
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
    Shimizu M; Takai K; Moriwaki H
    Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant therapy after treatment of hepatocellular carcinoma].
    Kasai K; Kuroda H; Suzuki K
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):787-94. PubMed ID: 18525183
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
    Shafritz DA
    N Engl J Med; 1996 Jun; 334(24):1600-1. PubMed ID: 8628344
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyprenoic acid in hepatocellular carcinoma.
    Yang CH; Cheng AL
    N Engl J Med; 1996 Nov; 335(19):1460-61; author reply 1461-2. PubMed ID: 8927081
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.
    Okuno M; Kojima S; Moriwaki H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1329-35. PubMed ID: 11851828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.
    Takai K; Okuno M; Yasuda I; Matsushima-Nishiwaki R; Uematsu T; Tsurumi H; Shiratori Y; Muto Y; Moriwaki H
    Intervirology; 2005; 48(1):39-45. PubMed ID: 15785088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.
    Muto Y; Moriwaki H; Shiratori Y
    Digestion; 1998 Jul; 59 Suppl 2():89-91. PubMed ID: 9718434
    [No Abstract]   [Full Text] [Related]  

  • 15. [Retinoid].
    Moriwaki H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():764-8. PubMed ID: 11762053
    [No Abstract]   [Full Text] [Related]  

  • 16. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.
    Muto Y; Moriwaki H; Saito A
    N Engl J Med; 1999 Apr; 340(13):1046-7. PubMed ID: 10189289
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of liver cancer: current strategies and future perspectives.
    Moriwaki H
    Int J Clin Oncol; 2002 Feb; 7(1):27-31. PubMed ID: 11942046
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.
    Sakai H; Shirakami Y; Shimizu M
    World J Gastroenterol; 2016 Jan; 22(1):394-406. PubMed ID: 26755885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma.
    Woo HY; Yoo SY; Heo J
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.